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HISTOLOGIC STUDIES OF NORMAL AND PSORIATIC EPIDEEMIS*
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STANLEY MINKOWITZ, M.D. AND PINDOS PETROU, M.D.
The clinical effectiveness of Methotrexate in
the management of psoriasis has been estab-
lished in the past ten years (1—3). Methotrexate
is generally believed to act as an antifolie
agent, thus influencing cells synthesizing
DNA in preparation for mitosis (4, 5). The
purpose of this study was to examine both
qualitative and quantitative aspects of the
morphological changes in normal and psoriatie
epidermis following treatment with Metho-
trexatef. In addition, an attempt was made to
correlate these findings with clinical observa-
tions.
MATERIALS AND METHODS
Six patients, 30 to 55 years of age, were studied,
four men and two women. All patients had psoria-
sis involving 50 per cent or more of their skin
surface. Methotrexatet, 50 mg, was given intra-
muscularly, and the interval between injections
varied from 7 to 12 days.
Skin biopsies.—In two of the six patients (Table
I and II), skin biopsy specimens were taken prior
to injection of Methotrexate, and also 24 hours,
72 hours, and one week later. This schedule was
followed throughout two (Table I) and three
(Table II) courses of treatment, respectively. In
the four additional patients, only two biopsy
specimens were taken, prior to, and 24 hours after
the administration of Methotrexate. At each time
interval, 4 mm punch biopsy specimens were ob-
tained on both normal and psoriatic skin, return-
ing to the same general area for later specimens.
Histology—In two of the six patients, samples
were fixed for 24 hours in cold Carnoy's fluid,
washed in 95 per cent alcohol, dehydrated in di-
oxane, embedded in paraffin, and sectioned at five
micra. Several non-consecutive sections were cut,
placed on at least two slides, and stained with a
modification of Masson's trichrome technic (Har-
ris hematoxylin, Poneeau acid fuchsin, and Fast
Green). Some sections were stained by the Feulgen
technic as described by Carleton and Drury (6).
The shdes from each patient were mixed and coded
arbitrarily for the histological studies, to minimize
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subjective errors. In the four additional patients,
skin biopsy specimens were fixed in formalin and
stained with hematoxylin eosin. All specimens
were carefully examined for dermal changes with
particular attention paid to the capillaries.
Mito tic counts—To study the slides from the
first two patients, (Table I and II) a Leits Dialux
microscope with apochromatic lenses was used, the
sections were examined qualitatively and the cells
were counted at a magnification of 1200x; a
square reticular ocular grid was used as a guide
to avoid duplicating counts. Eight to ten thousand
epidermal cells, from basal layer through stratum
granulosum were counted with a hand tally, simul-
taneously recording mitotic figures and pyknotie
epidermal cells. Results from individual slides were
calculated separately and were found to be satis-
factorily reproducible. The data in Tables I and
II represent averages for both slides from each
specimen. In all six cases, the number of pyknotie
epidermal cells per two mm section was counted
in at least six sections per patient from specimens
taken 24 hours after Methotrexatc injection (Table
III).
Histologic measurementst.—For the two pa-
tients in Tables I and II, each of the six sections
was projected on white paper at a magnification
of lSx. The outline of the junction between the
dermis and epidermis, i.e., the path of the base-
ment membrane was traced, including the islands
of dermis within the epidermis where papillae had
been cut tangentially. The free surface of the
stratum corneum and its junction with the under-
lying epidermis were also traced. The total length
of the projected drawing, representing the length
at the skin surface, was measured with a mm ruler,
and the length of the basement membrane or der-
mal-epidermal junction (including dermal islands)
underlying this surface was determined in mm
with a map measure. These results were reported
in terms of the ratio of the dermal-epidermal
junction, or basement membrane, to the surface
length. The thickness of the epidermis not includ-
ing the stratum corneum, was measured at regu-
larly spaced intervals, five measurements per sec-
tion of normal skin, and ten measurements per
section of psoriatic skin, with half of the meas-
urements at the tips of papillae and half in the
deepest regions. Drawings were made for six sec-
tions per specimen, and thickness and basement
membrane surface length ratios were calculated
t Thanks are due to Dr. Philip Prose and Dr.
Marvin Kuschner, Department of Pathology, New
York University, who reviewed the histologic sec-
tions in the initial stage of the study.
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for each individual drawing. These figures were
often identical for drawings of the same specimen,
and never differed by more than 2 per cent. The
figures were averaged to obtain the results reported
in Tables I and II.
Clinical response—All patients were evaluated
clinically after each course of Methotrexate. Im-
provement was estimated by one of the authors
(PP.) who was in daily contact with the patients.
Four grades of (1) poor, (2) fair, (3) good, and(4) excellent were used. Gradings were based on
decrease of erythema and scaling of psoriatic le-
sions.
RESULTS
Untreated psoriatic skin —Both eases
showed histologic changes typical of psoriasis.
There were numerous mitotic figures, located
chiefly within the first two or three rows of
cells from the basement membrane. The average
thickness of the epidermis excluding stratum
corneum was increased by a factor of three.
This increase involved aeanthosis, for in both
cases, the ratio of basement membrane length
to skin surface was greater in psoriatic skin
(Tables I and II).
Changes characteristic of psoriasis were also
seen in the dermis.
Psoriatic skin 24 hours after met hot rexate
injection—Both dermis and epidermis showed
essentially no overall tissue change from the
pre-injection state, except for two major and
apparently related changes. First, mitotic
figures were no longer prominent, they had
decreased to 0.000 per cent in one case (Table
I) and to 0.045 per cent (Table II) in the
other. The lowered mitotie index had not in-
fluenced the aeanthosis for the basement mem-
brane surface length ratio, and the epidermal
thickness were not different from pre-injection
values. Secondly, pyknotie epidermal cells
(Fig. lc & id) were found in large numbers,
(0.93% in Table I and 1.25% in Table II)
in the two or three cell layers adjacent to
the basement membrane. These cells had
brightly acidophilic cytoplasm and small ho-
mogeneously dark nuclei with completely
clumped chromatin, and some of the nuclei
were fragmented (Fig. id). These nuclei were
Feulgen-positive. Occasional cells with pro-
phase nuclei were seen (Fig. ib) and it was
possible to find forms constituting a transition
series, through progressively increased chro-
matin clumping to the pyknotic forms de-
scribcd above (Figs. lb, le). Clinically, no
change was observed in the skin.
Psoriatic skin 72 hours after Methotrexate
injection.—T here was a marked decrease of
parakeratosis in one case, and cells of the
stratum granulosum had become granulated
(Table II). However, inhibition of mitosis,
present earlier, no longer prevailed. Mitoses
had increased to 2.14 per cent (Table I) and
0.56 per cent (Table II) and pyknotie epi-
dermal cells were virtually absent; no pyknotie
cells were found in the superficial layers of the
epidermis despite the fact that 48 hours
earlier, they were numerous in the two or
three deepest layers. In both eases, the epi-
dermal thickness and the basement membrane to
surface length ratio tended to decrease com-
pared with the levels observed 24 hours after
injection of Methotrexate.
Clinical observation revealed some decrease
in scaling and erythema in both eases, more
apparent on the upper trunk and extremities.
Psoriotic skin one week after Methotrexote
injection .—T he microscopic appearance of
the psoriatic skin was essentially the same
as before Methotrexate treatment and mitoses
were numerous. However, in both eases, the
stratum granulosum had reappeared, and this
change was more pronounced in the patient
J.T. In patient P.S., the epidermal thickness
had returned to the pre-injection level, but
the basement membrane surface length ratio still
appeared to reflect some decrease in aeanthosis.
In patient J.T., epithelial thickness appeared
to have remained somewhat decreased, but
aeanthosis was as pronounced as before Metho-
trexate injection. Clinically, the first case (P.S.)
showed marked improvement. The second case,
(J.T.) showed only fair response (Table III).
Effects of repeated injection of Met hotrexate
on psoriatic skin.—Subsequent injections of
Methotrexate to these two patients produced
results essentially similar to those obtained
with the first injection. Patient P.S. consist-
ently showed a greater fall of mitotie index
to 0.000% while patient J.T. retained 0.045,
0.03 and 0.08 per cent mitoses, respectively,
in the psoriatic skin 24 hours after each in-
jection of Methotrexate. Histologically, there
was no summation of effect in skin which
still remained psoriatic, except that in both
eases the stratum granulosum, which had
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TABLE I (PS.)
DATE
SOURCE OF TISSUE TREATMENT
NUMBER OF CELLS
COUNTED
%
MITOSES PYKNOTIC CELLS
EPITHELIAL
HICKNESS*
BASEMENT
MEMBRANE LENGTH
SURFACE LENGTH
(mml (mm/mm)
2/10/65 Normal 5OrngMTX 8636 0.05 0.00 0.061 1.4
Psoriotic injected 10284 0.67 0.00 0. 158 3.1
2/11/65 Normal 8041 0.01
—
0.02 0.056 1.05
Psoriatic 7880 0.000 0.93 0.198 3.4
2/13/65 Normal 7820 0.07 0.00 0.074 1.3
Psoriatic 9892 2.14 0.04 0.157 2.5
2/17/65 Normal 6497 0 04 0 00 0 073 1.4
Psoriatic 7411 0.62 0.01 0.157 2.05
2/23/65 5OmgMTX
injected
2/24/65 Norma! 7152 0.04 0.00 0.070 1.5
Psoriatic 6684 0.000 0.80 0.141 3.0
M*
2/26/65 Normal 4275 0.3 0.00 0.098 1.2
Psoriatic 8112 0.74 0.01 0.152 2.36
e Epithet/al thickness except for stratum corneurn.
* e Biopsy bken too close to involved skin.
METH CT A E X ATE
TABLE II (J.T
DATE
SOURCE OF TISSUE TREATMENT
NUMBER OF CELLS
COUNTED
%
MITOSES
TEPITHELIAL%
PYKNOTIC CELLS THICKNESS*
BASEMENT
MEMBRANE LENGTH
SURFACE LENGTH
' (mm) (mm/mm)
3/9/65 Normal 5OmgMTX 8409 0.24 0.02 0.046 1,9
Psoriatic injected 8249 0.63 0.00 0. 164 2.55
3/10/65 Normal 7362 0.05 0.03 0.043 1,2
Psoriatic 8784 0.045 1.25 0.171 2,85
3/12/65 Normal 9246 0.09 0.00 0.049 1.1
Psoriatic 8355 0.56 0.00 0,135 2.25
3/17/65 Normal 5643 0. 12 0.00 0.040 1.1
Psoriatic 8790 0.52 0.03 0, 137 2.75
3/18/65 50mg MTXinjected
3/19/65 Normal 6052 0.035 0.00 0.036 1.0
Psoriatic 11465 0,03 0.42 0.139 2.2
3/21/65 Normal 5948 0.25 0.00 0.026 1.15
Psoriatic 12293 073 0.05 0. 104 25
3/25/65 Normal 5OmgMTX 7536 0.13 0.00 0.019 1.0
Psoriotic injected 7464 0.55 0.05 0.110 2,4
3/26/65 Normal 7087 0.06 0.00 0.043 1.55
Psoriatic 9749 0.08 0.83 0.183 2.5
,e Epithelial thickness except for stratum cornewn
M ET HOT REX AT E
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shown improvement one week after the first
injection, seemed to remain present and nor-
mal keratinization resumed. Again, this change
was more pronounced in patient J.T. reported
in Table II. Clinically, patient P.S. showed
excellent response after the second course of
Methotrexatc. However, the clinical response of
patient J.T. was only fair (Table III).
Untreated normal skin—The mitotic index
of untreated normal skin differed in the two
patients reported in Tables I and II; there were
0.05 per cent and 0.24 per cent mitoses, re-
spectively, before treatment. This difference
persisted in all subsequent specimens: in the
first patient P.S., all mitotic counts in Table
I averaged 0.05% in normal skin, excluding
biopsy specimens taken 24 hours after injec-
tion and the last biopsy specimen which was
taken too close to a lesion. In the second pa-
tient) J.T., mitoses were consistently more
2/26/65
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numerous, averaging 0.16%, excluding normal
skin biopsy specimens taken 24 hours alter
each injection.
Normal skin 24 hours after Methotrexate in-
jection.—In the first patient, P.S., normal skin
showed some lowering of mitotic index 24
hours alter the first injection, but none fol-
lowing the second. In the second patient, J.T.,
mitotic index of normal skin was reduced
alter each injection. Finally, only one or two
pyknotic epidcrmal cells were encountered in
the many thousands of cells examined in the
various normal skin biopsy specimens 24 hours
after injection. No other change was appar-
ent.
Correlation of histologic and clinical re-
sults.—Thc number of pyknotic epidermal cells
24 hours after treatment in all six patients
is reported in Table III, together with the
results of clinical observations over a period
of four weeks. The first patient, with sixty-
two pyknotic cells (C.C.), showed good clini-
cal response. Patients C.M., J.G., P.S., J.T.,
with roughly similar numbers of pyknotic
cells, showed a range of poor to excellent clini-
cal responses. Thus, one of the two striking
histologic changes seen 24 hours after injec-
tion bore no relationship to the eventual
effectiveness of the drug.
On the other hand, psoriatic lesions from
P.S. showed a lower mitotic index, 0.000 per
cent after each of two injections of Metho-
trexate, than lesions from J.T., with 0.04, 0.03,
and 0.08 per cent mitoses 24 hours after each
injection. The clinical response of patient P.S.
was excellent, while patient J.T. showed only
fair response. An additional case with poor
clinical response (J.G.) showed 0.108 per cent
mitoses in 8,449 cells counted 24 hours after
Methotrexatc has been injected (Table III).
DIscussIoN
Assuming that Methotrexate acts as a folic
acid antagonist in the highly proliferative
psoriatic epidermis, it was felt that detailed
histologic studies of sequential biopsy speci-
mens following the injection of Methotrexatc
might provide information concerning the
mechanism of action of this drug on tissue
organization, and on the dynamic aspects of
the lesion. A total of 28 punch skin biopsy
specimens from two patients was studied
(Tables I and II) and the first striking change
observed was an effect on mitotic index, as
previously reported by Van Scott and Reinert-
son (7). Twenty-four hours after the first
Mcthotrcxate injection, there was a pronounced
reduction of mitosis in the psoriatic lesions,
and subsequent courses yielded comparable re-
sults. Seventy-two hours after injection, mi-
totic indices had returned to at least pre-
injection levels in both patients and the action
of the drug on this parameter was very
transient.
In the thorough studies of Van Scott and
Ekel (8), mitotic indices were expressed in
terms of the reproductive cell population, de-
fined as the cells of the basal layer in the
normal skin and the cells of the three layers
adjacent to the basement membrane in psori-
atic skin. To apply this last definition, three-
dimensional reconstructions from serial sec-
tions must be prepared because mitoses and
interphase cells within three layers of the
basement membrane on the sides of deep der-
mal papillae may, in an adjacent section, ap-
pear far from the underlying basement mem-
brane. Since only single sections were studied
and no clear definition of potentially repro-
ductive cells was possible, it was considered
more reliable to express mitotic counts in
terms of the total cell population, including
all nucleated cells of the stratum gcrminativum,
stratum spinosum, and of the stratum granu-
losum, when present. In view of the differences
in epithelial thickness, no comparison of mi-
totic index was made between normal and
psoriatic skin.
The second striking change seen in psoriatic
skin 24 hours after injection of Methotrexate,
was the presence of pyknotic cells, presumed
to be of epidermal origin. The nuclear mor-
phology was so characteristic that in Feulgen-
stained slides with no counter-stain, the nuclei
were easily distinguished from other irregu-
larly shaped nuclei, such as those of migrating
leukocytes. The distribution of pyknotic cells
within the layers of the epidermis was
essentially similar to that of mitotic figures
in the psoriatic skin before Methotrexatc was
administered, and their numbers were of the
same order of magnitude, or greater, than the
numbers of mitotic figures seen in psoriatic
skin before injection. These facts arc in keep-
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TABLE fl
PATIENT
TOTAL NUMBER OF PYKNOTIC CELLS
COUNTEO IN 2 mm, LONG SECTION
PRIOR 24 HOURS AFTER
METHOTREXATE METHOTREXATE
CLINICAL RESPONSE
AFTER SECOND COURSE
OF METHOTREXATE
CC. 0 62 GOOD
G.M 0 I 22 GOOD
R.F 0 36 FAIR
JO. 0 23 POOR
RS. 0 21 EXCELLENT
J.T I 24 FAIR
* Average from sin oecf ions each 2 mm. long
ing with the suggestion that pyknotic cells
are of epidermal origin and may hear some
relationship to the mitotic process. In addition
to these cells with pyknotic nuclei, there were
cells with nuclei showing apparent chromo-
some formation which were not typical pro-
phases. The chromatin material was clumped
in elongated masses somewhat more gross than
chromosomes; these masses were accumulated
against the nuclear membrane in a helical or
circular pattern, and the nuclei were not as
enlarged as in typical prophase. A progressive
series showing increasing degrees of chromatin
clumping and nuclear shrinkage can be con-
structed (Fig. ib, lc). The "inclusion bodies"
described by Trier (9) in cells from human
intestinal crypts following Methotrexate ad-
ministration, greatly resemble the pyknotic
epidermal cells described above. Inasmuch as
the cell turnover for psoriatic skin has been
estimated to be of the order of four days
(8, 10) one could expect to find some of these
cells in the superficial layers 72 hours after
Methotrexate had been injected. Since none
were seen, it seems reasonable to conclude that
these cells are truly pyknotic and had been
lysed in the period from 24 to 72 hours after
injection.
In Carnoy-fixed specimens of psoriatic skin,
the cells, particularly in the stratum spinosum,
contained large, predominantly basophilic cyto-
plasm and large vesicular nuclei with promi-
nent nucleoli and nuclear membrane. These
characteristics could possibly reflect a less dif-
ferentiated state, for similarly fixed and
stained specimens of normal skin showed
Fio. la. Untreated psoriatic skin, with a typical early prophase indicated by the arrow.
The cytoplasm of the mitotic cell shows greatly reduced staining density. Photographs were
taken at a magnification of 910 X.
Fxo. lb. Psoriatic skin 24 hours after Methotrexate. A figure resembling early prophase
is indicated by the arrow. The chromatin is largely accumulated at the nuclear membrane,
but the cytoplasm does not show reduced staining density as in typical prophase. Figures
so closely resembling prophase were very rare.
Fjo. ic. Psoriatic skin 24 hours after Methotrexate. The nucleus indicated by the arrow I,
shows coarse chromatin, clumped as a band adhering to the nuclear membrane. (This is a
face view of a flattened, spiralling band, seen by altering the depth of focus). Arrow 2 indi-
cates a cell with further nuclear shrinkage, a typical pyknotic epidermal cell. Arrow 3 mdi-
cates a leukocyte nucleus, comparable in size, but the nucleolus and nuclear membrane are
yosible. The staining and hyaline nature of the cytoplasm of the pyknotie cells, not evident
in these photographs, was another feature in their identification.
Fm. id. Psoriatic skin 24 hours after Methotrexate, showing a pyknotic epidermal cell
with nuclear fragmentation (arrow I). A tortuous capillary lined by enlarged endothelial
cells is also indicated (arrow 2).
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smaller, darker staining nuclei and acidophilie
cytoplasm, presumably due to tonofibrils and
specific protein synthesis (keratin precursors).
This is not a general characteristic of le-
sions involving acanthosis, for a similarly
fixed and stained specimen from a patient
with neurodermatitis showed cells with acido-
philie cytoplasm, well-stained tonofibrils, and
more densely stained nuclei. Treatment with
Methotrexate did not change this cytologic
aspect of psoriatie lesions except in one in-
stance in which the cytoplasm became some-
what more acidophilie 7 days after the Meth-
otrexate injection.
The average thickness of the epidermis was
measured and the ratio of basement mein-
brane to surface length was determined in an
effort to quantitate any possible change in
overall epidermal morphology in response to
Methotrexate (as done by Van Scott and
Reinertson (7)).
The epithelial thickness and basement mem-
brane to surface length ratios were both mark-
edly increased in psoriatie skin and re-
mained unchanged 24 hours after injection,
but 72 hours after injection, both tended to
decrease slightly in both patients. Slight
changes were still in evidence one week after
injection, in one patient, epidermal thickness
was still somewhat lower, although acanthosis
was now pronounced (Table II), whereas in
the other (Table I), slightly reduced acanthosis
persisted, but epidermal thickness had returned
to the pre-injeetion level. The temporary mitotic
inhibition was too brief to produce any lasting
or pronounced effects on overall epidermal
structure.
One change which seemed to persist within
involved areas, particularly in the patient
studied in Table II, was a restoration of typi-
cal stratum granulosum cells and some clearing
of mieroabseesses.
Biopsy specimens taken before and after
injection of Methotrexate were also examined
for dermal changes. The typical vascular pathol-
ogy persisted throughout the two-three courses
of Methotrexate. Furthermore, in the first
case, despite a marked decrease of erythema
clinically, one could still detect the presence
of enlarged tortuous capillaries histologically.
One of the aims of this investigation was
to seek some means of predicting whether or
not a patient would show clinical improve-
ment upon continued treatment with Metho-
trexate. There are marked latitudes of response
to the drug in various individuals, and it
would be of value to estimate the expected re-
sponse, preferably after one injection. No clini-
cal criteria were found, and attention was
consequently focused upon the histologic fea-
tures of the biopsy specimens. The pyknotie
epidermal cells seen 24 hours after injection
were a major striking change observed in re-
sponse to Methotrexate, aside from the mitotic
inhibition, but, as seen in Table Ill, no cor-
relation was found to exist between the num-
ber of pyknotie cells (in a total of 12mm of
skin, expressed as an average for 2mm) and
the eventual clinical response in the six pa-
tients studied. On the other hand, 24 hours
after each injection, the patient reported in
Table I, who eventually showed excellent clini-
cal improvement, consistently showed fewer
mitoses in psoriatie skin than the patient
reported in Table H, who showed a far less
satisfactory clinical response. In an attempt to
support this finding, the mitotie index was
determined in the formalin-fixed specimen
from the patient J.G. (Table III) who also
showed poor clinical response, and again, it
was found that many mitotic figures were
present 24 hours after injection of Methotrexate.
These observations could be clinically useful,
and should be investigated further.
SUMMARY
Histologic and histometric studies were
carried out in normal and psoriatic skin
obtained by punch biopsy removal from six
patients treated with Methotrexate. The ma-
jor change observed 24 hours after injection
was a marked decrease in mitotic index, to-
gether with the appearance of pyknotic epi-
dermal cells and abnormal prophases. The lo-
cation and number of pyknotie cells suggest
that they bear some relationship to the mitotic
process.
Detailed studies during two and three courses
of treatment with Methotrexate in two of these
patients showed that 72 hours after injection,
mitotie index had returned at least to pre-
injection levels or higher, and that the pyknotic
cells were not longer in evidence. Epidermal
thickness and acanthosis were measured and no
lasting change was produced. No change was
observed in the dermis.
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AD attempt was made to fiDd an index of
future response to treatment by correlating the
findings 24 hours after injection with the
eventual clinical course in the six patients
studied. The numbers of pyknotic cells did
not bear any relationship to the clinical im-
provement. However, of the two patients
studied through several courses of treatment,
the patient consistently showing incomplete
mitotic arrest 24 hours after each injection also
showed poor clinical response.
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